ARTICLE | Company News
Clal, Hyperion deal
June 16, 2014 7:00 AM UTC
Hyperion completed its acquisition of Clal's Andromeda Biotech Ltd. subsidiary for about $20.5 million in cash and stock up front. Clal received $12.5 million in cash and 312,869 Hyperion shares valu...